Repligen Director Sells $44K in RGEN Stock in Minor Transaction
REPLIGEN CORP
Subscribe to track RGEN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Repligen Director Sells $44K in RGEN Stock
Company: REPLIGEN CORP (RGEN) Form: 4 | Filed: 2025/12/18 Significance: Low
Insider: DAWES KAREN A Title: null | Relationship: Director
Transaction: • Type: Sell • Shares: 275 • Price: $161.00 • Value: $44,275 • Owned After: 91,821
Key Insight: A director sold a very small amount of stock, representing an insignificant portion of their holdings and the company's total shares. This trade is likely for personal financial management and is not considered a significant market signal.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: REPLIGEN CORP (RGEN)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director executed a minor sale of company stock, valued at approximately $44,275.
- Market Impact: The transaction is too small to have any meaningful impact on the stock or market sentiment.
Company Information
| Field | Value |
|---|---|
| Company | REPLIGEN CORP |
| Ticker Symbol | RGEN |
| CIK | 0000730272 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | DAWES KAREN A |
| CIK | 0001261506 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-17 |
| Transaction Code | S (Open market or private sale) |
| Security Type | Common Stock |
| Shares Involved | 275 |
| Price Per Share | $161.00 |
| Total Value | $44,275 |
| Shares Owned After | 91,821 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $44,275 |
| % of Market Cap | <0.001% |
| Shares Transacted | 275 |
| % of Shares Outstanding | <0.001% |
| Post-Transaction Ownership | 91,821 shares (0.16% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $44,275 transaction is negligible compared to Repligen's $8.58 billion market capitalization.
- Ownership Concentration: The sale represents a tiny fraction (<0.3%) of the director's total holdings and does not materially change their ownership stake.
- Transaction Significance: The trade's value is less than 0.001% of the company's market cap and the shares involved are less than 0.001% of total shares outstanding, confirming its low significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is de minimis and carries no informational value for the market. It is likely related to personal portfolio management or tax planning.
Volume & Sentiment
- Expected Volume Impact: None. The transaction size is too small to affect trading volume.
- Sentiment Indicator: Neutral. This filing is unlikely to influence investor sentiment.
Additional Context
Transaction Notes
- The sale was a routine, open-market transaction with no special circumstances noted in the filing.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.